Validation of the RSClin risk calculator in the National Cancer Data Base.
Augustin G L VannierAsim DhunganaFangyuan ZhaoNan ChenSarah ShubeckOlwen M HahnRita NandaNora T JaskowiakGini F FlemingOlufunmilayo I OlopadeAlexander T PearsonDezheng HuoFrederick M HowardPublished in: Cancer (2023)
RSClin may identify high-risk patients who benefit from treatment intensification more accurately than OncotypeDx, and further prospective study is needed.
Keyphrases